Cargando…
Endostatin and ST2 are predictors of pulmonary hypertension disease course in infants.
INTRODUCTION: Pulmonary hypertension (PH) is a common comorbidity of cardiopulmonary disease. Endostatin, an inhibitor of angiogenesis, is elevated in neonates with lung disease. ST2 is a heart failure biomarker correlated with PH in adults. We hypothesized that these biomarkers may be useful in dia...
Autores principales: | Griffiths, Megan, Yang, Jun, Everett, Allen D., Jennings, Jacky M., Freire, Grace, Williams, Monica, Nies, Melanie, McGrath-Morrow, Sharon A., Collaco, Joseph M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7578107/ https://www.ncbi.nlm.nih.gov/pubmed/32366869 http://dx.doi.org/10.1038/s41372-020-0671-8 |
Ejemplares similares
-
Risk Factors and Clinical Outcomes in Preterm Infants with Pulmonary Hypertension
por: Collaco, Joseph M., et al.
Publicado: (2016) -
Patterns of early life somatic growth in infants and children with a history of chronic lung disease of prematurity
por: Aoyama, Brianna C., et al.
Publicado: (2023) -
Bronchopulmonary dysplasia: what are its links to
COPD?
por: McGrath-Morrow, Sharon A., et al.
Publicado: (2019) -
The angiostatic peptide endostatin enhances mortality risk prediction in pulmonary arterial hypertension
por: Simpson, Catherine E., et al.
Publicado: (2021) -
Angiostatic Peptide, Endostatin, Predicts Severity in Pediatric Congenital Heart Disease–Associated Pulmonary Hypertension
por: Daly, Caroline M., et al.
Publicado: (2021)